A new drug originating from cottonseeds could be used to treat the re-emergence of the most lethal type of brain cancer, researchers have suggested.
Scientists at the University of Alabama have pioneered the new cancer treatment, which has shown promise in preventing the reoccurrence of glioblastoma multiforme.
During a clinical trial, it was shown that the pill, known as AT-101, is capable of overcoming the abnormal growth patterns of tumour cells.
According to professor John Fiveash, the lead researcher of the study, AT-101 halted the progression of cancer in "many of the 56 patients" involved in the trial.
"After getting this drug some of these patients went many months without any new growth in their tumours," he explained.
"We are able to do that with a well-tolerated oral medication, and that is a major benefit."
Professor Fiveash added that the drug would be most effective when used in conjunction with radiation and chemotherapy, which would improve the cancer-fighting properties of those particular treatments.
Approximately one in every 5,000 people is affected by brain cancer